Former Fellows
|
Fellow |
Thesis |
Thesis Mentor |
Current Institution |
|
Sarah Ackroyd, MD 2020-2023 |
Pembrolizumab and Lenvatinib versus Carboplatin and Paclitaxel as first line therapy for advanced or recurrent endometrial cancer: A Markov Analysis |
Elbert Huang, MD and Nita Lee, MD, MPH | The University of Chicago |
|
Melissa Javellana, MD 2019-2022 |
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer |
Ernst Lengyel, MD, PhD |
The University of Kansas Medical Center |
|
Raanan Alter, MD 2018-2021 |
Strategies to reverse immunosuppression in PTEN deficient gynecologic cancers by tumor cell intrinsic STING/IFN-B signaling |
Akash Patnaik, MD |
Northwestern Medicine |
|
Isabel Lazo, MD 2017-2020 |
Profiling metabolite changes in the ovarian cancer secretome and its impact on alterations in human primary mesothelial cells |
Ernst Lengyel, MD, PhD Hilary Kenny, PhD |
Stanford Medicine |
|
Claire Hoppenot, MD, PhD 2016-2019 |
Genomics and proteomics of long-term survivors of advanced-stage high-grade serous ovarian cancer |
Ernst Lengyel, MD, PhD |
Baylor College of Medicine |
|
Jerlinda Ross, MD, MS 2015-2018 |
Endometrial Cancer Survivor’s Access to Recommended Self-Care Resources for Obesity in a High-Poverty Urban Community |
Stacy Lindau, MD, MAPP Nita Lee, MD, MPH |
Medical University of South Carolina |
|
Josephine Kim, MD 2014-2017 |
Combination simvastatin/metformin for endometrial cancer treatment and prevention |
Gustavo Rodriguez, MD |
University of Chicago |
|
Terri Febbraro, MD 2013-2016 |
Inhibition of BI integrin impedes ovarian cancer metastasis via redirection in lactate production resulting in decreased proliferation, angiogenesis and cancer stem cell population |
Ernst Lengyel, MD, PhD |
MaineHealth Medical Center |
|
Andrea Jewel, MD 2012-2015 |
MicroRNA 206 is associated with longer overall survival and platinum sensitivity in serous epithelial ovarian cancer |
Ernst Lengyel, MD, PhD |
The University of Kansas Health System |
|
Andras Ladyani, MD 2011-2014 |
Expression of fatty acid transporters in ovarian cancer |
Ernst Lengyel, MD, PhD |
Rush University Medical Center |
|
Jessica Hunn, MD 2011-2014 |
Developing an effective pharmacologic approach for the chemoprevention of ovarian and uterine cancer |
Gustavo Rodriguez, MD |
Valley Women’s Health |